Search research articles
Contact Us
Filters
Showing results (141-150 of 272) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661
Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients
Robin Parihar, Padma Nadella, Adrian Lewis, et al.
Blood
|
March 18, 2006
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways
Latha P Ganesan, Trupti Joshi, Huiqing Fang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 21, 2025
The association between allostatic load and lymphedema in breast cancer survivors
Barnabas Obeng-Gyasi, Yevgeniya Gokun, Mohamed I Elsaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12
Charles F Eisenbeis, Gregory B Lesinski, Mirela Anghelina, et al.
Veterinary Immunology and Immunopathology
|
April 4, 2013
Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells
Dong-Jun Shin, Ji-Yun Park, Youn-Young Jang, et al.
Protein Science : a Publication of the Protein Society
|
March 8, 2016
Structural characterization of NRAS isoform 5
Joseph Markowitz, Tapas K Mal, Chunhua Yuan, et al.
The Journal of Clinical Investigation
|
July 17, 2003
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse
Gregory B Lesinski, Mirela Anghelina, Jason Zimmerer, et al.
NPJ Breast Cancer
|
June 12, 2024
Allostatic load as a predictor of postoperative complications in patients with breast cancer
J C Chen, Mohamed I Elsaid, Demond Handley, et al.
Cancers
|
February 24, 2024
Roles of Androgen Receptor Signaling in Urothelial Carcinoma
Debasish Sundi, Katharine A Collier, Yuanquan Yang, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 272) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661
Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients
Robin Parihar, Padma Nadella, Adrian Lewis, et al.
Blood
|
March 18, 2006
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways
Latha P Ganesan, Trupti Joshi, Huiqing Fang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 21, 2025
The association between allostatic load and lymphedema in breast cancer survivors
Barnabas Obeng-Gyasi, Yevgeniya Gokun, Mohamed I Elsaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12
Charles F Eisenbeis, Gregory B Lesinski, Mirela Anghelina, et al.
Veterinary Immunology and Immunopathology
|
April 4, 2013
Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells
Dong-Jun Shin, Ji-Yun Park, Youn-Young Jang, et al.
Protein Science : a Publication of the Protein Society
|
March 8, 2016
Structural characterization of NRAS isoform 5
Joseph Markowitz, Tapas K Mal, Chunhua Yuan, et al.
The Journal of Clinical Investigation
|
July 17, 2003
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse
Gregory B Lesinski, Mirela Anghelina, Jason Zimmerer, et al.
NPJ Breast Cancer
|
June 12, 2024
Allostatic load as a predictor of postoperative complications in patients with breast cancer
J C Chen, Mohamed I Elsaid, Demond Handley, et al.
Cancers
|
February 24, 2024
Roles of Androgen Receptor Signaling in Urothelial Carcinoma
Debasish Sundi, Katharine A Collier, Yuanquan Yang, et al.
Page
of 28